JP Morgan Chase
THRD

JP Morgan Chase’s Third Harmonic Bio THRD Stock Holding History

JP Morgan Chase’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-95,538
Closed -$519K – 7724
2025
Q2 		$519K Sell
95,538
-168,877
-64% -$842K ﹤0.01% 4762
2025
Q1 		$918K Buy
264,415
+228,268
+631% +$1.11M ﹤0.01% 4409
2024
Q4 		$372K Buy
36,147
+22,735
+170% +$283K ﹤0.01% 5186
2024
Q3 		$182K Sell
13,412
-28
-0.2% -$347 ﹤0.01% 5451
2024
Q2 		$175K Sell
13,440
-428,701
-97% -$5.3M ﹤0.01% 5229
2024
Q1 		$4.17M Sell
442,141
-572,134
-56% -$5.56M ﹤0.01% 3244
2023
Q4 		$11.1M Buy
1,014,275
+1,001,315
+7,726% +$7.93M ﹤0.01% 2357
2023
Q3 		$82.8K Sell
12,960
-2,564
-17% -$15.7K ﹤0.01% 5600
2023
Q2 		$74.7K Buy
15,524
+258
+2% +$1.23K ﹤0.01% 5597
2023
Q1 		$63K Sell
15,266
-3,612
-19% -$15.3K ﹤0.01% 5622
2022
Q4 		$81K Buy
+18,878
New +$316K ﹤0.01% 5436

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase's THRD Position: Q3 2025 in Review

JP Morgan Chase sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 95,538 shares — an estimated $519K sold.

JP Morgan Chase first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $11.1M in Q4 2023. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • JP Morgan Chase reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • JP Morgan Chase sold 95,538 Third Harmonic Bio shares in Q3 2025, an estimated $519K.
  • JP Morgan Chase first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • JP Morgan Chase's Third Harmonic Bio position peaked at $11.1M in Q4 2023.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.